Pioglitazone as Add-on THERAPY in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Dapagliflozin and Metformin: Double-Blind, Randomized, Placebo-Controlled Trial

CONCLUSION: Triple therapy with the addition of 15 mg/day of pioglitazone to dapagliflozin plus metformin was well tolerated and produced significant improvements in HbA1c in patients with T2DM inadequately controlled with dapagliflozin plus metformin.PMID:38310875 | DOI:10.4093/dmj.2023.0314

Source: Diabetes and Metabolism Journal - February 4, 2024 Category: Endocrinology Authors: Ji Hye Heo Kyung Ah Han Jun Hwa Hong Hyun-Ae Seo Eun-Gyoung Hong Jae Myung Yu Hye Seung Jung Bong-Soo Cha Source Type: research